Broadwood Partners Lp, Director, Ten Percent Owner at Lineage Therap, holds 9.86M shares in OncoCyte (Ticker: OCX), holds 83.42M shares in Lineage Therap (Ticker: LCTX), holds 21.56M shares in Staar Surgical (Ticker: STAA). Most recently, Broadwood Partners Lp Bought ― shares of OncoCyte on Apr 15, 2024 for an estimated value of 7.04M.